Sep 29, 2026 07:05AM
Sep 29, 2026 07:05AM
Jun 29, 2026 07:09AM
Jun 2, 2026 08:41AM
May 27, 2026 06:50AM
May 13, 2026 06:51AM
May 12, 2026 07:05AM Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
Apr 7, 2026 04:31PM
Apr 6, 2026 08:38AM
Apr 2, 2026 06:43AM
Apr 1, 2026 06:59AM
Mar 30, 2026 07:05AM
Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM FDA accepts Unicycive drug application resubmission with June review date
Jan 29, 2026 07:05AM
Dec 29, 2025 07:05AM
Dec 29, 2025 07:05AM
Dec 2, 2025 12:39PM
Nov 12, 2025 08:36AM
Nov 12, 2025 07:05AM
Oct 28, 2025 07:06AM Unicycive expects to resubmit drug application by year-end after FDA meeting
Oct 28, 2025 07:05AM
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM
Jun 10, 2025 06:00AM
May 21, 2025 08:48AM
May 14, 2025 07:15AM
Apr 10, 2025 09:14AM Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
Apr 10, 2025 08:00AM
Apr 1, 2025 07:00AM
Apr 1, 2025 06:46AM
Mar 31, 2025 07:00AM
Mar 13, 2025 07:00AM
Feb 20, 2025 07:02AM
Feb 20, 2025 07:00AM Unicycive Therapeutics Announces the Publication of Preclinical Data on Synergies Between Oxylanthanum Carbonate and Tenapanor in American Society of Nephrology Journal Kidney360
Jan 28, 2025 07:02AM
Jan 28, 2025 07:00AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Dec 17, 2024 07:00AM
Nov 21, 2024 07:00AM
Nov 13, 2024 07:15AM Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
Nov 12, 2024 07:52AM
Nov 11, 2024 07:01AM
Nov 11, 2024 07:00AM
Sep 7, 2024 08:00PM
Sep 4, 2024 07:27AM
Sep 3, 2024 07:03AM
Sep 3, 2024 07:03AM Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Di

15,923 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All